Comparative genomic and transcriptomic analyses unveil novel features of azole resistance and adaptation to the human host in Candida glabrata

The frequent emergence of azole resistance among Candida glabrata strains contributes to increase the incidence of infections caused by this species. Whole-genome sequencing of a fluconazole and voriconazole-resistant clinical isolate (FFUL887) and subsequent comparison with the genome of the susceptible strain CBS138 revealed prominent differences in several genes documented to promote azole resistance in C. glabrata. Among these was the transcriptional regulator CgPdr1. The CgPdr1 FFUL887 allele included a K274Q modification not documented in other azole-resistant strains. Transcriptomic profiling evidenced the upregulation of 92 documented targets of CgPdr1 in the FFUL887 strain, supporting the idea that the K274Q substitution originates a CgPdr1 gain-of-function mutant. The expression of CgPDR1K274Q in the FFUL887 background sensitised the cells against high concentrations of organic acids at a low pH (4.5), but had no detectable effect in tolerance towards other environmental stressors. Comparison of the genome of FFUL887 and CBS138 also revealed prominent differences in the sequence of adhesin-encoding genes, while comparison of the transcriptome of the two strains showed a significant remodelling of the expression of genes involved in metabolism of carbohydrates, nitrogen and sulphur in the FFUL887 strain; these responses likely reflecting adaptive responses evolved by the clinical strain during colonisation of the host.

[1]  H. Ferreira,et al.  Xanthomonas citri MinC Oscillates from Pole to Pole to Ensure Proper Cell Division and Shape , 2017, Front. Microbiol..

[2]  E. Beaudoing,et al.  Comparative Genomics of Two Sequential Candida glabrata Clinical Isolates , 2017, G3: Genes, Genomes, Genetics.

[3]  Othilde Elise Håvelsrud,et al.  Draft Genome Sequences of Candida glabrata Isolates 1A, 1B, 2A, 2B, 3A, and 3B , 2017, Genome Announcements.

[4]  N. Mira,et al.  Mechanistic Insights Underlying Tolerance to Acetic Acid Stress in Vaginal Candida glabrata Clinical Isolates , 2017, Front. Microbiol..

[5]  Catarina Costa,et al.  The PathoYeastract database: an information system for the analysis of gene and genomic transcription regulation in pathogenic yeasts , 2016, Nucleic Acids Res..

[6]  Markus S. Schröder,et al.  The CgHaa1-Regulon Mediates Response and Tolerance to Acetic Acid Stress in the Human Pathogen Candida glabrata , 2016, G3: Genes, Genomes, Genetics.

[7]  L. Johnson,et al.  Current Trends in Candidemia and Species Distribution Among Adults: Candida glabrata Surpasses C. albicans in Diabetic Patients and Abdominal Sources. , 2016 .

[8]  Nan Xu,et al.  Genome Sequencing of the Pyruvate-producing Strain Candida glabrata CCTCC M202019 and Genomic Comparison with Strain CBS138 , 2016, Scientific Reports.

[9]  M. Kołaczkowski,et al.  Drug resistance mechanisms and their regulation in non-albicans Candida species. , 2016, The Journal of antimicrobial chemotherapy.

[10]  N. Gow,et al.  The Rewiring of Ubiquitination Targets in a Pathogenic Yeast Promotes Metabolic Flexibility, Host Colonization and Virulence , 2016, PLoS pathogens.

[11]  B. Alexander,et al.  Prevalent mutator genotype identified in fungal pathogen Candida glabrata promotes multi-drug resistance , 2016, Nature Communications.

[12]  Miguel C. Teixeira,et al.  Membrane Proteome-Wide Response to the Antifungal Drug Clotrimazole in Candida glabrata: Role of the Transcription Factor CgPdr1 and the Drug:H+ Antiporters CgTpo1_1 and CgTpo1_2* , 2015, Molecular & Cellular Proteomics.

[13]  博章 加藤.  ATP Binding Cassetteトランスポーターの構造薬理学 , 2014 .

[14]  V. Srivastava,et al.  Pivotal Role for a Tail Subunit of the RNA Polymerase II Mediator Complex CgMed2 in Azole Tolerance and Adherence in Candida glabrata , 2014, Antimicrobial Agents and Chemotherapy.

[15]  Miguel C. Teixeira,et al.  Candida glabrata drug:H+ antiporter CgTpo3 (ORF CAGL0I10384g): role in azole drug resistance and polyamine homeostasis. , 2014, The Journal of antimicrobial chemotherapy.

[16]  H. Jungwirth,et al.  Systematic Phenotyping of a Large-Scale Candida glabrata Deletion Collection Reveals Novel Antifungal Tolerance Genes , 2014, PLoS pathogens.

[17]  Miguel C. Teixeira,et al.  MFS multidrug transporters in pathogenic fungi: do they have real clinical impact? , 2014, Front. Physiol..

[18]  S. G. Chadwick,et al.  UPC2A Is Required for High-Level Azole Antifungal Resistance in Candida glabrata , 2014, Antimicrobial Agents and Chemotherapy.

[19]  B. Turcotte,et al.  Phenotypic Analysis of a Family of Transcriptional Regulators, the Zinc Cluster Proteins, in the Human Fungal Pathogen Candida glabrata , 2014, G3: Genes, Genomes, Genetics.

[20]  S. Ranque,et al.  Interactions between copy number and expression level of genes involved in fluconazole resistance in Candida glabrata , 2013, Front. Cell. Infect. Microbiol..

[21]  J. Šubík,et al.  Mutation of the CgPDR16 gene attenuates azole tolerance and biofilm production in pathogenic Candida glabrata , 2013, Yeast.

[22]  K. Kugiyama,et al.  The heme-binding protein Dap1 links iron homeostasis to azole resistance via the P450 protein Erg11 in Candida glabrata. , 2013, FEMS yeast research.

[23]  A. De Las Peñas,et al.  Local silencing controls the oxidative stress response and the multidrug resistance in Candida glabrata , 2013, Molecular microbiology.

[24]  Ronald N. Jones,et al.  Echinocandin and Triazole Antifungal Susceptibility Profiles for Clinical Opportunistic Yeast and Mold Isolates Collected from 2010 to 2011: Application of New CLSI Clinical Breakpoints and Epidemiological Cutoff Values for Characterization of Geographic and Temporal Trends of Antifungal Resistance , 2013, Journal of Clinical Microbiology.

[25]  Hironobu Nakayama,et al.  The Candida glabrata sterol scavenging mechanism, mediated by the ATP‐binding cassette transporter Aus1p, is regulated by iron limitation , 2013, Molecular microbiology.

[26]  S. Leibundgut-Landmann,et al.  Gain-of-Function Mutations in PDR1, a Regulator of Antifungal Drug Resistance in Candida glabrata, Control Adherence to Host Cells , 2013, Infection and Immunity.

[27]  T. Myers,et al.  STB5 Is a Negative Regulator of Azole Resistance in Candida glabrata , 2012, Antimicrobial Agents and Chemotherapy.

[28]  Jay H. Konieczka,et al.  Convergent Evolution of Calcineurin Pathway Roles in Thermotolerance and Virulence in Candida glabrata , 2012, G3: Genes | Genomes | Genetics.

[29]  S. Avery,et al.  Heterogeneous Expression of the Virulence-Related Adhesin Epa1 between Individual Cells and Strains of the Pathogen Candida glabrata , 2011, Eukaryotic Cell.

[30]  K. Yanagihara,et al.  Functional characterization of the regulators of calcineurin in Candida glabrata. , 2011, FEMS yeast research.

[31]  K. Sekimizu,et al.  Intestinal Resident Yeast Candida glabrata Requires Cyb2p-Mediated Lactate Assimilation to Adapt in Mouse Intestine , 2011, PloS one.

[32]  Rupinder Kaur,et al.  The Rho1 GTPase-activating Protein CgBem2 Is Required for Survival of Azole Stress in Candida glabrata* , 2011, The Journal of Biological Chemistry.

[33]  M. Ghannoum,et al.  Clinical breakpoints for voriconazole and Candida spp. revisited: review of microbiologic, molecular, pharmacodynamic, and clinical data as they pertain to the development of species-specific interpretive criteria. , 2011, Diagnostic microbiology and infectious disease.

[34]  B. Posteraro,et al.  Contribution of CgPDR1-Regulated Genes in Enhanced Virulence of Azole-Resistant Candida glabrata , 2011, PloS one.

[35]  Hironobu Nakayama,et al.  Transcription factors CgUPC2A and CgUPC2B regulate ergosterol biosynthetic genes in Candida glabrata , 2011, Genes to cells : devoted to molecular & cellular mechanisms.

[36]  Ramin Homayouni,et al.  Genomewide Expression Profile Analysis of the Candida glabrata Pdr1 Regulon , 2010, Eukaryotic Cell.

[37]  Sanjoy Paul,et al.  Regulation of the CgPdr1 Transcription Factor from the Pathogen Candida glabrata , 2010, Eukaryotic Cell.

[38]  T. Myers,et al.  Microarray and Molecular Analyses of the Azole Resistance Mechanism in Candida glabrata Oropharyngeal Isolates , 2010, Antimicrobial Agents and Chemotherapy.

[39]  A. Rodloff,et al.  Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-Year Analysis of Susceptibilities of Candida Species to Fluconazole and Voriconazole as Determined by CLSI Standardized Disk Diffusion , 2010, Journal of Clinical Microbiology.

[40]  J. Cleary,et al.  Effect of Candida glabrata FKS1 and FKS2 Mutations on Echinocandin Sensitivity and Kinetics of 1,3-β-d-Glucan Synthase: Implication for the Existing Susceptibility Breakpoint , 2009, Antimicrobial Agents and Chemotherapy.

[41]  G. Fadda,et al.  Gain of Function Mutations in CgPDR1 of Candida glabrata Not Only Mediate Antifungal Resistance but Also Enhance Virulence , 2009, PLoS pathogens.

[42]  G. Fadda,et al.  The ATP‐binding cassette transporter–encoding gene CgSNQ2 is contributing to the CgPDR1‐dependent azole resistance of Candida glabrata , 2008, Molecular microbiology.

[43]  J. Šubík,et al.  Functional characterization of the CgPGS1 gene reveals a link between mitochondrial phospholipid homeostasis and drug resistance in Candida glabrata , 2008, Current Genetics.

[44]  Hironobu Nakayama,et al.  The Candida glabrata putative sterol transporter gene CgAUS1 protects cells against azoles in the presence of serum. , 2007, The Journal of antimicrobial chemotherapy.

[45]  K. Kuchler,et al.  The High-Osmolarity Glycerol Response Pathway in the Human Fungal Pathogen Candida glabrata Strain ATCC 2001 Lacks a Signaling Branch That Operates in Baker's Yeast , 2007, Eukaryotic Cell.

[46]  G. Butler,et al.  Transcriptional Response of Candida parapsilosis following Exposure to Farnesol , 2007, Antimicrobial Agents and Chemotherapy.

[47]  C. Hennequin,et al.  Reduced Susceptibility to Polyenes Associated with a Missense Mutation in the ERG6 Gene in a Clinical Isolate of Candida glabrata with Pseudohyphal Growth , 2006, Antimicrobial Agents and Chemotherapy.

[48]  R. Homayouni,et al.  Pdr1 regulates multidrug resistance in Candida glabrata: gene disruption and genome‐wide expression studies , 2006, Molecular microbiology.

[49]  J. Bennett,et al.  Candida glabrata PDR1, a Transcriptional Regulator of a Pleiotropic Drug Resistance Network, Mediates Azole Resistance in Clinical Isolates and Petite Mutants , 2006, Antimicrobial Agents and Chemotherapy.

[50]  G. Fadda,et al.  Mechanisms of Azole Resistance in Clinical Isolates of Candida glabrata Collected during a Hospital Survey of Antifungal Resistance , 2005, Antimicrobial Agents and Chemotherapy.

[51]  B. Arthington-Skaggs,et al.  Rapid Acquisition of Stable Azole Resistance by Candida glabrata Isolates Obtained before the Clinical Introduction of Fluconazole , 2005, Antimicrobial Agents and Chemotherapy.

[52]  T. Edlind,et al.  Azole Resistance in Candida glabrata: Coordinate Upregulation of Multidrug Transporters and Evidence for a Pdr1-Like Transcription Factor , 2004, Antimicrobial Agents and Chemotherapy.

[53]  D. Tweardy,et al.  INFECTION AND IMMUNITY , 2006, Infection and Immunity.

[54]  M. Bard,et al.  Candida glabrata erg1 Mutant with Increased Sensitivity to Azoles and to Low Oxygen Tension , 2004, Antimicrobial Agents and Chemotherapy.

[55]  B. Dujon,et al.  Genome evolution in yeasts , 2004, Nature.

[56]  B. Cormack,et al.  Functional Genomic Analysis of Fluconazole Susceptibility in the Pathogenic Yeast Candida glabrata: Roles of Calcium Signaling and Mitochondria , 2004, Antimicrobial Agents and Chemotherapy.

[57]  D. Denning,et al.  Method for the determination of minimum inhibitory concentration (MIC) by broth dilution of fermentative yeasts , 2003 .

[58]  J. Oxford,et al.  Treatment of epidemic and pandemic influenza with neuraminidase and M2 proton channel inhibitors. , 2003, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[59]  A. Goffeau,et al.  Functional dissection of Pdr1p, a regulator of multidrug resistance in Saccharomyces cerevisiae , 2002, Molecular Genetics and Genomics.

[60]  D. Sanglard,et al.  The ATP Binding Cassette Transporter GeneCgCDR1 from Candida glabrata Is Involved in the Resistance of Clinical Isolates to Azole Antifungal Agents , 1999, Antimicrobial Agents and Chemotherapy.

[61]  J. Sobel,et al.  Candida glabrata: Review of Epidemiology, Pathogenesis, and Clinical Disease with Comparison toC. albicans , 1999, Clinical Microbiology Reviews.

[62]  D. Ward,et al.  Fluconazole Resistance Associated with Drug Efflux and Increased Transcription of a Drug Transporter Gene, PDH1, inCandida glabrata , 1998, Antimicrobial Agents and Chemotherapy.

[63]  A. Levine,et al.  Gain of function mutations in p53 , 1993, Nature Genetics.

[64]  M. Luck,et al.  Genome sequencing , 1987, Nature.

[65]  Mechanistic insights , 2022 .